BARD1 Antibodies

Liu, Ao, Jia, Bai, Xu, Hu, Jiang, Chen, Wu: "FOXK2 transcription factor suppresses ER?-positive breast cancer cell growth through down-regulating the stability of ER? via mechanism involving BRCA1/BARD1." in: Scientific reports, Vol. 5, pp. 8796, (2015) (PubMed).

Tembe, Martino-Echarri, Marzec, Mok, Brodie, Mills, Lei, DeFazio, Rizos, Kettle, Boadle, Henderson: "The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function." in: Cellular signalling, Vol. 27, Issue 9, pp. 1763-71, (2015) (PubMed).

Jerjees, Alabdullah, Green, Alshareeda, Macmillan, Ellis, Rakha: "Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer." in: Breast cancer research and treatment, Vol. 145, Issue 2, pp. 317-30, (2014) (PubMed).

Alshareeda, Negm, Green, Nolan, Tighe, Albarakati, Sultana, Madhusudan, Ellis, Rakha: "SUMOylation proteins in breast cancer." in: Breast cancer research and treatment, Vol. 144, Issue 3, pp. 519-30, (2014) (PubMed).

Bosse, Diskin, Cole, Wood, Schnepp, Norris, Nguyen, Jagannathan, Laquaglia, Winter, Diamond, Hou, Attiyeh, Mosse, Pineros, Dizin, Zhang, Asgharzadeh, Seeger, Capasso, Pawel, Devoto, Hakonarson et al.: "Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. ..." in: Cancer research, Vol. 72, Issue 8, pp. 2068-78, (2012) (PubMed).

Mok, Henderson: "The in vivo dynamic organization of BRCA1-A complex proteins at DNA damage-induced nuclear foci." in: Traffic (Copenhagen, Denmark), Vol. 13, Issue 6, pp. 800-14, (2012) (PubMed).

Zhang, Pilyugin, Kuester, Leoni, Li, Casula, Zorcolo, Schneider-Stock, Atzori, Irminger-Finger: "Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome." in: British journal of cancer, Vol. 107, Issue 4, pp. 675-83, (2012) (PubMed).

Chapman, Sossick, Boulton, Jackson: "BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair." in: Journal of cell science, Vol. 125, Issue Pt 15, pp. 3529-34, (2012) (PubMed).

Wu, Sato, Koike, Nishikawa, Koizumi, Venkitaraman, Ohta: "HERC2 is an E3 ligase that targets BRCA1 for degradation." in: Cancer research, Vol. 70, Issue 15, pp. 6384-92, (2010) (PubMed).

Batchelder, Gordon-Weeks, Walker: "Altered expression of anti-apoptotic proteins in non-involved tissue from cancer-containing breasts." in: Breast cancer research and treatment, Vol. 114, Issue 1, pp. 63-9, (2009) (PubMed).